The CB307 study expansion involves the addition of a new pembrolizumab combination cohort

The company will utilise Qureight’s AI technology to undergo studies across a variety of complex lung diseases

Empowering younger doctors is central to why consultant trauma and orthopaedic surgeon Usman Ahmed has become a role […]

People with a learning disability from a minority ethnic background have a life expectancy of just 34 years—around […]

Informed consent in the medical context is defined in the Oxford Dictionary as “permission from a patient for […]

Updated Date: Mon, 17 Jul 2023 00:00:00 EDT

Updated Date: Mon, 17 Jul 2023 00:00:00 EDT

Updated Date: Mon, 17 Jul 2023 00:00:00 EDT

Updated Date: Mon, 17 Jul 2023 00:00:00 EDT

Updated Date: Mon, 17 Jul 2023 00:00:00 EDT